media – Page 692 – DrugDu- Global Leading Pharmaceutical & Medical Device Platform

This Drug Has Significant Implications for Heart Disease

An anti-inflammatory drug has significantly lowered the risk of recurrent heart attacks, strokes and cardiovascular death, all without reducing cholesterol, according to research recently published in the New England Journal of Medicine and shared at a meeting of the European Society of Cardiology.
- Source: newsjs
- 629
- August 31, 2017
anti-inflammatory cardiovascular Clinical Trials heart attacks stroke
FDA Approves New Antibiotics to Treat Kidney Infections by “Superbugs”

Adult peoples with complicated urinary tract infections (cUTI) like pyelonephritis– a type of kidney infection caused by specific bacteria- suffer from many inconvenient problems like painful urination. It may lead to serious life threatening conditions including permanent kidney damage.
- Source: medgenera
- 785
- August 31, 2017
cUTI kidney New Approvals pyelonephritis
NIH develops robotic exoskeleton to treat crouch gait in children

A robotic exoskeleton for the treatment of crouch (or flexed-knee) gait in children with cerebral palsy has been developed by US researchers from the Rehabilitation Medicine department of the NIH Clinical Centre.
- Source: medicaldevice-network
- 703
- August 30, 2017
cerebral Crouch gait Researches
EUSA bags EU approval for kidney cancer drug

The European Commission has licensed EUSA Pharma’s Fotivda for the management of adult patients with advanced kidney cancer across the European Union as well as Norway and Iceland.
- Source: open-medical
- 616
- August 30, 2017
cancer inhibitor kidney New Approvals
MedGenome raises $30m for biomarker discovery program

MedGenomeGenomics research and diagnostics company MedGenome said today that it closed a $30 million Series C round led by Sequoia India and Sofina. Zodius Capital, the co-founder & former CEO of Infosys, Kris Gopalakrishnan, and former Cognizant CEO Lakshmi Narayanan also participated in the round.
- Source: drugdeliverybusiness
- 649
- August 30, 2017
genetic immunotherapy Market Views Series
Europe’s first stem cell therapy backed by NICE

Chiesi's Holoclar, the first stem-cell therapy to be cleared by European regulators, has received a green light for use on the NHS in England and Wales to treat a rare sight condition.
- Source: pharmatimes
- 940
- August 29, 2017
New Approvals NHS stem-cell therapy
Resonetics Acquires Aduro Laser, Adds Disruptive Manufacturing Capability for Laser Cut Tubing

Resonetics announced today its acquisition of Aduro Laser, an emerging leader in laser processing of tubular components for the medical device industry.
- Source: prnewswire
- 550
- August 29, 2017
acquisition Company Insight laser Market Views
“Body-on-a-chip” device screens human heart cells for drug toxicity

A "body-on-a-chip" device that can evaluate the side-effects of drugs on human cells has been developed by researchers at Kyoto University's Institute for Integrated Cell-Material Sciences, according to a study published today in the Royal Society of Chemistry Advances.
- Source: drugdeliverybusiness
- 625
- August 29, 2017
doxorubicin Researches side-effect toxicity
Ddu Attended Pharma Asia-Boosting the Belt and Road Initiative

The 13th Health Asia & Pharma Asia International Exhibition & Conferences (Pharma Asia) was held at the Karachi Expo Center from August 22nd to August 24th 2017. As the leading global pharmaceutical and medical device B2B online platform, Ddu attended the exhibition introducing their new cross-border medical trade online method to Pakistan.
- Source: Ddu
- 890
- August 29, 2017
Exhibitions & Activities Pakistan Pharma Asia
Ddu Attended the 2017 CPhI Korea-Establishing a Good Reputation for Services

The 2017 CPhI Korea was grandly held at the Convention Center Grand Ball Room, Seoul, South Korea from August 22nd to August 24th. Ddu, the leading global pharmaceutical and medical device B2B online platform, attended the exhibition where their management concept and service method proved why they are a leader in their field.
- Source: Ddu
- 1,329
- August 29, 2017
CPhI Exhibitions & Activities Korea

your submission has already been received.

OK

Subscribe

Please enter a valid Email address！

Submit

The most relevant industry news & insight will be sent to you every two weeks.

more

more

Customer Services
Contact Us
Help Center

Buy on Drugdu.com
Browse Product Categories

Free APP

Follow Us

Terms & Conditions | Privacy Policy

粤ICP备16008861号

Copyright © 2016-2018 Drugdu.com. All Rights Reserved.